Novel agents in the treatment of Waldenström's macroglobulinemia.

Treon, Steven P; Hatjiharissi, Evdoxia; Leleu, Xavier; Moreau, Anne-Sophie; Roccaro, Aldo; Hunter, Zachary R; Soumerai, Jacob D; Ciccarelli, Bryan; Xu, Lian; Sacco, Antonio; Ngo, Hai T; Jia, Xiaoying; Yang, Cao; Adamia, Sophia; Branagan, Andrew R; Ho, Allen W; Santos, Daniel D; Tournilhac, Olivier; Manning, Robert J; Leduc, Renee; O'Connor, Kelly; Nelson, Marybeth; Patterson, Christopher J; Ghobrial, Irene

Treon, Steven P; Hatjiharissi, Evdoxia; Leleu, Xavier; Moreau, Anne-Sophie; Roccaro, Aldo; Hunter, Zachary R; Soumerai, Jacob D; Ciccarelli, Bryan; Xu, Lian; Sacco, Antonio; Ngo, Hai T; Jia, Xiaoying; Yang, Cao; Adamia, Sophia; Branagan, Andrew R; Ho, Allen W; Santos, Daniel D; Tournilhac, Olivier; Manning, Robert J; Leduc, Renee; O'Connor, Kelly; Nelson, Marybeth; Patterson, Christopher J; Ghobrial, Irene.

Afiliação

Treon SP; Bing Center for Waldenström's Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA 02115, USA. steven_treon@dfci.harvard.edu

Clin Lymphoma Myeloma ; 7 Suppl 5: S199-206, 2007 Aug.

Article em En | MEDLINE | ID: mdl-17877845

Assuntos

Antineoplásicos/uso terapêutico; Fatores Imunológicos/uso terapêutico; Inibidores de Proteases/uso terapêutico; Macroglobulinemia de Waldenstrom/tratamento farmacológico; Animais; Humanos

Buscar no Google

Imprimir

XML

PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Macroglobulinemia de Waldenstrom / Fatores Imunológicos / Antineoplásicos Limite: Animals / Humans Idioma: En Ano de publicação: 2007 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links